HDL/Apolipoprotein A-I Binds to Macrophage-Derived Progranulin and Suppresses its Conversion into Proinflammatory Granulins
-
- Okura Hanayuki
- Department of Somatic Stem Cell Therapy, Institute of Biomedical Research and Innovation, Foundation for Biomedical Research and Innovation. Division of Cardiovascular Surgery, Department of Surgery, Osaka University Graduate School of Medicine. Research Fellow of the Japan Society for the Promotion of Science.
-
- Yamashita Shizuya
- Division of Cardiology, Department of Internal Medicine, Osaka University Graduate School of Medicine.
-
- Ohama Tohru
- Division of Cardiology, Department of Internal Medicine, Osaka University Graduate School of Medicine.
-
- Saga Ayami
- Department of Somatic Stem Cell Therapy, Institute of Biomedical Research and Innovation, Foundation for Biomedical Research and Innovation.
-
- Yamamoto-Kakuta Aya
- Department of Somatic Stem Cell Therapy, Institute of Biomedical Research and Innovation, Foundation for Biomedical Research and Innovation.
-
- Hamada Yoko
- Department of Somatic Stem Cell Therapy, Institute of Biomedical Research and Innovation, Foundation for Biomedical Research and Innovation.
-
- Sougawa Nagako
- Department of Somatic Stem Cell Therapy, Institute of Biomedical Research and Innovation, Foundation for Biomedical Research and Innovation.
-
- Ohyama Reiko
- Department of Somatic Stem Cell Therapy, Institute of Biomedical Research and Innovation, Foundation for Biomedical Research and Innovation.
-
- Sawa Yoshiki
- Division of Cardiovascular Surgery, Department of Surgery, Osaka University Graduate School of Medicine.
-
- Matsuyama Akifumi
- Department of Somatic Stem Cell Therapy, Institute of Biomedical Research and Innovation, Foundation for Biomedical Research and Innovation.
Search this article
Abstract
Aim: HDL has anti-inflammatory effects on macrophages, although the mechanism of action remains unclear. We hypothesized that HDL suppresses the conversion of macrophage-secreted factors into proinflammatory factors via binding, and tried to identify the factor that could form a complex with HDL and/or apolipoprotein (apo) A-I.<BR>Methods and Results: In conditioned media obtained from human monocyte-derived macrophages, we found an apo A-I binding protein and identified the protein as progranulin/proepithelin/acrogranin/PCDGF. Co-immunoprecipitation analysis showing that progranulin binds and forms a complex with apo A-I and the presence of progranulin in the HDL fraction in the sera indicated that progranilin is a novel apolipoprotein. Conditioned media of HEK293 cells transfected with progranulin augmented the expression of TNF-alpha and IL-1-beta on macrophages, but these effects of progranulin were inhibited by co-incubation with HDL or apo A-I. Anti-progranulin antibodies also reduced the expression of TNF-alpha and IL-1-beta on macrophages. Granulins as conversion products derived from progranilin increased TNF-alpha and IL-1-beta expression and the effects were not suppressed by HDL.<BR>Conclusions: Our results suggest that the anti-inflammatory effects of HDL on macrophages might be due to suppression of the conversion of progranulin into proinflammatory granulins by forming a complex.
Journal
-
- Journal of Atherosclerosis and Thrombosis
-
Journal of Atherosclerosis and Thrombosis 17 (6), 568-577, 2010
Japan Atherosclerosis Society
- Tweet
Details 詳細情報について
-
- CRID
- 1390282679409166080
-
- NII Article ID
- 130004845317
-
- DOI
- 10.5551/jat.3921
-
- ISSN
- 18803873
- 13403478
-
- Text Lang
- en
-
- Data Source
-
- JaLC
- Crossref
- CiNii Articles
-
- Abstract License Flag
- Disallowed